• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

既往接受立体定向消融放疗后行冷冻消融治疗导致的严重胸壁毒性反应

Severe Chest Wall Toxicity From Cryoablation in the Setting of Prior Stereotactic Ablative Radiotherapy.

作者信息

Chaudhuri Aadel A, Binkley Michael S, Aggarwal Sonya, Qian Yushen, Carter Justin N, Shah Rajesh, Loo Billy W

机构信息

Department of Radiation Oncology, Stanford University School of Medicine.

Department of Interventional Radiology, Stanford University School of Medicine.

出版信息

Cureus. 2016 Feb 2;8(2):e477. doi: 10.7759/cureus.477.

DOI:10.7759/cureus.477
PMID:27004154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4780688/
Abstract

We present the case of a 42-year-old woman with metastatic synovial sarcoma of parotid origin, treated definitively with chemoradiation, who subsequently developed oligometastatic disease limited to the lungs. She underwent multiple left and right lung wedge resections and left lower lobectomy, followed by right lower lobe stereotactic ablative radiotherapy (SABR), 54 Gy in three fractions to a right lower lobe lesion abutting the chest wall. Two years later, she was treated with cryoablation for a separate right upper lobe nodule abutting the chest wall. Two months later, she presented with acute shortness of breath, pleuritic chest pain, decreased peripheral blood O2 saturation, and productive cough. A computed tomography (CT) scan demonstrated severe chest wall necrosis in the area of recent cryoablation that, in retrospect, also received a significant radiation dose from her prior SABR. This case demonstrates that clinicians should exercise caution in using cryoablation when treating lung tumors abutting a previously irradiated chest wall. Note: Drs. Loo and Shah contributed equally as co-senior authors.

摘要

我们报告了一例42岁女性,患有腮腺来源的转移性滑膜肉瘤,接受了放化疗的根治性治疗,随后出现局限于肺部的寡转移疾病。她接受了多次左右肺楔形切除术和左肺下叶切除术,随后对右肺下叶与胸壁相邻的病变进行了立体定向消融放疗(SABR),分三次给予54 Gy。两年后,她因右肺上叶一个与胸壁相邻的独立结节接受了冷冻消融治疗。两个月后,她出现急性气短、胸膜炎性胸痛、外周血氧饱和度降低和咳痰。计算机断层扫描(CT)显示,在最近冷冻消融的区域出现严重胸壁坏死,回顾发现该区域之前也接受了来自SABR的高剂量辐射。该病例表明,临床医生在治疗与先前接受过放疗的胸壁相邻的肺部肿瘤时,使用冷冻消融应谨慎。注意:卢医生和沙阿医生作为共同资深作者贡献相同。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ee4/4780688/f5562d436a14/cureus-0008-000000000477-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ee4/4780688/27d42d8548f2/cureus-0008-000000000477-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ee4/4780688/4032ee7c5f23/cureus-0008-000000000477-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ee4/4780688/f5562d436a14/cureus-0008-000000000477-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ee4/4780688/27d42d8548f2/cureus-0008-000000000477-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ee4/4780688/4032ee7c5f23/cureus-0008-000000000477-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ee4/4780688/f5562d436a14/cureus-0008-000000000477-i03.jpg

相似文献

1
Severe Chest Wall Toxicity From Cryoablation in the Setting of Prior Stereotactic Ablative Radiotherapy.既往接受立体定向消融放疗后行冷冻消融治疗导致的严重胸壁毒性反应
Cureus. 2016 Feb 2;8(2):e477. doi: 10.7759/cureus.477.
2
Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors.立体定向消融放疗(SABR)治疗中央型和超中央型肺部肿瘤。
Lung Cancer. 2015 Jul;89(1):50-6. doi: 10.1016/j.lungcan.2015.04.014. Epub 2015 May 4.
3
PET/CT features of lung SABR chest wall toxicity.肺部立体定向消融放疗(SABR)所致胸壁毒性的 PET/CT 特征。
J Med Imaging Radiat Oncol. 2021 Feb;65(1):92-94. doi: 10.1111/1754-9485.13115. Epub 2020 Oct 25.
4
A Case of Metastatic Head and Neck Squamous Cell Carcinoma with Multiple Treatments Including Stereotactic Ablative Body Radiotherapy Alone for Oligometastases to the Parotid Gland.一例转移性头颈部鳞状细胞癌的病例,接受了多种治疗,包括仅对腮腺寡转移灶进行立体定向消融体部放疗。
Cureus. 2015 Dec 28;7(12):e438. doi: 10.7759/cureus.438.
5
Predictors of chest wall toxicity after stereotactic ablative radiotherapy using real-time tumor tracking for lung tumors.使用实时肿瘤追踪技术对肺肿瘤进行立体定向消融放疗后胸壁毒性的预测因素。
Radiat Oncol. 2017 Apr 5;12(1):66. doi: 10.1186/s13014-017-0803-2.
6
Lung stereotactic ablative radiotherapy (SABR): dosimetric considerations for chest wall toxicity.肺部立体定向消融放疗(SABR):胸壁毒性的剂量学考量
Br J Radiol. 2016;89(1058):20150628. doi: 10.1259/bjr.20150628.
7
Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.立体定向消融放疗与标准放疗治疗Ⅰ期非小细胞肺癌(TROG 09.02 CHISEL):一项 III 期、开放性标签、随机对照临床试验。
Lancet Oncol. 2019 Apr;20(4):494-503. doi: 10.1016/S1470-2045(18)30896-9. Epub 2019 Feb 12.
8
Primary lung sarcoma treated with stereotactic ablative radiotherapy: a case report.立体定向消融放疗治疗原发性肺肉瘤:一例报告
Onco Targets Ther. 2017 Jul 4;10:3285-3288. doi: 10.2147/OTT.S138595. eCollection 2017.
9
Predictors of Chest Wall Toxicity after Lung Stereotactic Ablative Radiotherapy.肺立体定向消融放疗后胸壁毒性的预测因素
Clin Oncol (R Coll Radiol). 2016 Jan;28(1):28-35. doi: 10.1016/j.clon.2015.06.009. Epub 2015 Jun 28.
10
A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).一项关于寡转移前列腺癌观察与立体定向消融放疗对比的II期随机试验(ORIOLE)。
BMC Cancer. 2017 Jun 29;17(1):453. doi: 10.1186/s12885-017-3455-6.

引用本文的文献

1
Safety and efficacy of iridium-192 high-dose-rate interstitial brachytherapy for pleural and chest wall tumours: preliminary results.铱-192高剂量率组织间近距离放射疗法治疗胸膜和胸壁肿瘤的安全性和疗效:初步结果
J Contemp Brachytherapy. 2025 Aug;17(4):213-220. doi: 10.5114/jcb.2025.153852. Epub 2025 Aug 26.
2
Cryoablation of Lung Metastases: Review of Recent Literature and Ablation Technique.肺转移瘤的冷冻消融:近期文献综述与消融技术
Semin Intervent Radiol. 2019 Oct;36(4):319-325. doi: 10.1055/s-0039-1697002. Epub 2019 Oct 31.
3
Observation of the effect of targeted therapy of 64-slice spiral CT combined with cryoablation for liver cancer.

本文引用的文献

1
Evaluating Cryoablation of Metastatic Lung Tumors in Patients--Safety and Efficacy: The ECLIPSE Trial--Interim Analysis at 1 Year.评估冷冻消融治疗转移性肺肿瘤患者的安全性和疗效:ECLIPSE 试验——1 年的中期分析。
J Thorac Oncol. 2015 Oct;10(10):1468-74. doi: 10.1097/JTO.0000000000000632.
2
Predictors of Chest Wall Toxicity after Lung Stereotactic Ablative Radiotherapy.肺立体定向消融放疗后胸壁毒性的预测因素
Clin Oncol (R Coll Radiol). 2016 Jan;28(1):28-35. doi: 10.1016/j.clon.2015.06.009. Epub 2015 Jun 28.
3
Computed tomographic appearance of lung tumors treated with percutaneous cryoablation.
64层螺旋CT联合冷冻消融靶向治疗肝癌的疗效观察
World J Gastroenterol. 2017 Jun 14;23(22):4080-4089. doi: 10.3748/wjg.v23.i22.4080.
经皮冷冻消融治疗肺肿瘤的 CT 表现。
J Vasc Interv Radiol. 2012 Aug;23(8):1043-52. doi: 10.1016/j.jvir.2012.04.033.
4
Incidence and risk factors for chest wall toxicity after risk-adapted stereotactic radiotherapy for early-stage lung cancer.风险适应立体定向放疗治疗早期肺癌后胸壁毒性的发生率及危险因素。
J Thorac Oncol. 2011 Dec;6(12):2052-7. doi: 10.1097/JTO.0b013e3182307e74.
5
Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT).从肺部立体定向体部放疗(SBRT)预测胸壁毒性。
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):974-80. doi: 10.1016/j.ijrobp.2010.12.002. Epub 2011 Feb 6.
6
Severe local toxicity after lung stereotactic body radiation therapy: lesional abscess leading to bronchocutaneous fistula requiring surgical marsupialization.
J Thorac Oncol. 2010 Nov;5(11):1874-5. doi: 10.1097/JTO.0b013e3181f13699.
7
Obesity increases the risk of chest wall pain from thoracic stereotactic body radiation therapy.肥胖增加了接受胸部立体定向体部放射治疗的患者发生胸壁疼痛的风险。
Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):91-6. doi: 10.1016/j.ijrobp.2010.04.022. Epub 2010 Jun 11.
8
Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy.胸部接受 >30 Gy 剂量的体积预测了肺癌立体定向体放射治疗后出现严重疼痛和/或肋骨骨折的风险。
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):796-801. doi: 10.1016/j.ijrobp.2009.02.027. Epub 2009 May 8.
9
Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications.腹部肿瘤的射频热消融:并发症带来的经验教训
Radiographics. 2004 Jan-Feb;24(1):41-52. doi: 10.1148/rg.241025144.